These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29276033)

  • 1. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
    Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
    Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
    Modi V; Lama D; Sankararamakrishnan R
    J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
    Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
    Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study.
    Chen Y; Wang J; Zhang J; Wang W
    J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors.
    Huhn AJ; Guerra RM; Harvey EP; Bird GH; Walensky LD
    Cell Chem Biol; 2016 Sep; 23(9):1123-1134. PubMed ID: 27617850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer.
    Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD
    Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A redox switch regulates the structure and function of anti-apoptotic BFL-1.
    Korshavn KJ; Wales TE; Bird GH; Engen JR; Walensky LD
    Nat Struct Mol Biol; 2020 Sep; 27(9):781-789. PubMed ID: 32661419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
    Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
    ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide.
    Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z
    Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim.
    Herman MD; Nyman T; Welin M; Lehtiö L; Flodin S; Trésaugues L; Kotenyova T; Flores A; Nordlund P
    FEBS Lett; 2008 Oct; 582(25-26):3590-4. PubMed ID: 18812174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.
    Fire E; Gullá SV; Grant RA; Keating AE
    Protein Sci; 2010 Mar; 19(3):507-19. PubMed ID: 20066663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
    Lama D; Sankararamakrishnan R
    J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.
    Chen L; Willis SN; Wei A; Smith BJ; Fletcher JI; Hinds MG; Colman PM; Day CL; Adams JM; Huang DC
    Mol Cell; 2005 Feb; 17(3):393-403. PubMed ID: 15694340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering.
    Harvey EP; Hauseman ZJ; Cohen DT; Rettenmaier TJ; Lee S; Huhn AJ; Wales TE; Seo HS; Luccarelli J; Newman CE; Guerra RM; Bird GH; Dhe-Paganon S; Engen JR; Wells JA; Walensky LD
    Cell Chem Biol; 2020 Jun; 27(6):647-656.e6. PubMed ID: 32413285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1.
    Jenson JM; Ryan JA; Grant RA; Letai A; Keating AE
    Elife; 2017 Jun; 6():. PubMed ID: 28594323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1.
    Gambini L; Udompholkul P; Baggio C; Muralidharan A; Kenjić N; Assar Z; Perry JJP; Pellecchia M
    J Med Chem; 2021 Apr; 64(8):4903-4912. PubMed ID: 33797903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands.
    Lee EF; Czabotar PE; Yang H; Sleebs BE; Lessene G; Colman PM; Smith BJ; Fairlie WD
    J Biol Chem; 2009 Oct; 284(44):30508-17. PubMed ID: 19726685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.